ANTI-TUMOR NECROSIS FACTOR

Open Access
Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study
Leslie R. Harrold, Heather J. Litman, Sean E. Connolly, Sheila Kelly, Winnie Hua, Evo Alemao, Lisa Rosenblatt, Sabrina Rebello and Joel M. Kremer

The Journal of Rheumatology January 1 2018, 45 (1) 32-39; DOI: https://doi.org/10.3899/jrheum.170007
You have access
Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors
Ennio Lubrano, Wendy J. Parsons and Fabio Massimo Perrotta

The Journal of Rheumatology May 1 2016, 43 (5) 918-923; DOI: https://doi.org/10.3899/jrheum.151404
You have access
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden
Lars Erik Kristensen, Elisabeth Lie, Lennart T.H. Jacobsson, Robin Christensen, Philip J. Mease, Henning Bliddal and Pierre Geborek

The Journal of Rheumatology January 1 2016, 43 (1) 81-87; DOI: https://doi.org/10.3899/jrheum.150744
You have access
The Effect of Intravenous Golimumab on Health-related Quality of Life in Rheumatoid Arthritis: 24-week Results of the Phase III GO-FURTHER Trial
Clifton O. Bingham III, Michael Weinblatt, Chenglong Han, Timothy A. Gathany, Lilianne Kim, Kim Hung Lo, Dan Baker, Alan Mendelsohn and Rene Westhovens

The Journal of Rheumatology June 1 2014, 41 (6) 1067-1076; DOI: https://doi.org/10.3899/jrheum.130864
You have access
Tuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor-α (TNF-α) Targeted Biologics and Recently Licensed TNF-α Inhibitors: Data from Clinical Trials and National Registries
Fabrizio Cantini, Laura Niccoli and Delia Goletti

The Journal of Rheumatology Supplement May 1 2014, 91 56-64; DOI: https://doi.org/10.3899/jrheum.140103
You have access
Restarting Biologics and Management of Patients with Flares of Inflammatory Rheumatic Disorders or Psoriasis During Active Tuberculosis Treatment
Fabrizio Cantini, Francesca Prignano and Delia Goletti

The Journal of Rheumatology Supplement May 1 2014, 91 78-82; DOI: https://doi.org/10.3899/jrheum.140106
You have access
Increase in Bone Density in Patients with Spondyloarthritis During Anti-Tumor Necrosis Factor Therapy: 6-year Followup Study
Anne Durnez, Simon Paternotte, Jacques Fechtenbaum, Robert B.M. Landewé, Maxime Dougados, Christian Roux and Karine Briot

The Journal of Rheumatology October 1 2013, 40 (10) 1712-1718; DOI: https://doi.org/10.3899/jrheum.121417

Main menu

User menu

Search

ANTI-TUMOR NECROSIS FACTOR

Content

Resources

Subscribers

More